Company profile for OBiO Technology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2013 and headquartered in Shanghai, OBiO is a biotechnology company focusing on gene and cell therapy field: serving as a contract research organization for vectorology and functional genomics studies and providing contract development and manufacturing services of IND-enabling CMC, clinical and commercial manufacturing. In recent years, in line with the mission of enabling gene therapy for better lives, OBiO has es...
Founded in 2013 and headquartered in Shanghai, OBiO is a biotechnology company focusing on gene and cell therapy field: serving as a contract research organization for vectorology and functional genomics studies and providing contract development and manufacturing services of IND-enabling CMC, clinical and commercial manufacturing. In recent years, in line with the mission of enabling gene therapy for better lives, OBiO has established core technologies around vectorology development, large-scale process development and manufacturing, facilitating a robust and versatile GMP manufacturing system for various gene and cell therapy products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Building No.19, Lane 908, Ziping Rd, Pudong New District, Shanghai
Telephone
Telephone
+86 400-151-5198
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/obio-technology-congratulates-on-the-first-clinical-gene-editing-therapy-to-treat-an-overseas-patient-in-china-by-correctsequence-therapeutics

PRESS RELEASE
06 Aug 2024

https://www.obio-tech.com/news-details/releases/21

PRESS RELEASE
15 Jun 2024

https://www.prnewswire.com/news-releases/obio-technology-officially-launched-the-center-for-clinical-evaluation-and-translation-of-advanced-therapies-for-pediatric-rare-and-genetic-diseases-302158742.html

PR NEWSWIRE
30 May 2024

https://www.obio-tech.com/news-details/releases/20

PRESS RELEASE
27 Apr 2024

https://www.obio-tech.com/news-details/releases/18

PRESS RELEASE
03 Apr 2024

https://www.obio-tech.com/news-details/releases/19

PRESS RELEASE
03 Apr 2024

ABOUT THIS PAGE

Contact OBiO Technology and get a quotation

OBiO Technology is a supplier offers 5 products (APIs, Excipients or Intermediates).

Find a price of D08 PLASMID bulk offered by OBiO Technology

Find a price of D03 PLASMID bulk offered by OBiO Technology

Find a price of D04 PLASMID bulk offered by OBiO Technology

Find a price of D01 PLASMID bulk offered by OBiO Technology

Find a price of D02 PLASMID bulk offered by OBiO Technology

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty